KELOWNA, British Columbia, Oct. 28, 2019 (GLOBE NEWSWIRE) — Allied Corp. (“Allied”) (OTCQB: ALID), an international health-related cannabis enterprise focused on developing and delivering targeted cannabinoid overall health options, is pleased to announce it has entered into a Master Solutions Agreement with the University of Haifa, Israel by means of their wholly owned commercialization subsidiary: Carmel – Haifa University Financial Corporation Ltd. (“Haifa”). This globe-class academic analysis center offers Allied access to a proprietary pre-clinical animal model that is owned by Carmel. Especially, Allied will engage with this proprietary animal model for the purposes of specialized pharmaceutical cannabinoid analysis and pharmaceutical solution improvement.
By way of this agreement, Allied now has access to Haifa’s top-edge facilities, proprietary animal model, pharmaceutical improvement, academic laboratory and linked scientists and investigators. This will allow Allied to conduct the pre-clinical phase of the improvement of a proprietary pharmaceutical solution for which Allied has patent-pending status. This pharmaceutical solution (“AC001”) targets the therapy of Post-Traumatic Tension Disorder and connected mental overall health circumstances. Following the completion of the pre-clinical analysis phase, Allied intends to bring AC001 via human clinical trials. Following this, Allied intends to then seek a international commercialization partnership via a licensing deal for solution AC001 with a significant pharma international commercialization companion.
“Building upon Allied’s existing patent-pending position, and as portion of Allied’s Intellectual House and Pharma Improvement (IP&PD) Tactic, we are excited to start pre-clinical testing of our novel formulations. This is outlined in the parameters of our current United States Provisional Patent Application for Cannabinoid and Terpenoid Pharmaceutical Compositions and Approaches for Treating Post-Traumatic Tension Disorder (PTSD)” says David Weinkauf, VP-Pharma Improvement for Allied Corp. “This is the 1st essential step towards Allied bringing an academically validated pharmaceutical solution to these who want it most these folks about the globe who have offered of themselves to serve their nation and are now suffering with PTSD”.
Added info about Allied Corp. can be located at www.allied.overall health.
On behalf of the Board,
Chief Executive Officer
About Carmel – Haifa University Financial Corporation Ltd.
Carmel-Haifa University Financial Corporation Ltd. serves as the commercialization and enterprise arm of the University of Haifa and is accountable for guarding and commercializing its intellectual house. Carmel-Haifa collaborates with different partners and establishes ventures, providers and funds with the purpose of maximizing the enterprise possible of commercializing analysis and know-how created at the University.
Added info about Carmel – Haifa can be located at http://carmel-ltd.haifa.ac.il
About Allied Corp.
Allied Corp. is an international cannabis enterprise with a mission to enable folks suffering from Post-Traumatic Tension Disorder (PTSD) by researching, developing and creating targeted cannabinoid overall health options. Allied Corp. utilizes an proof-informed scientific strategy to make this mission doable, via cutting-edge pharmaceutical analysis and improvement, revolutionary plant-primarily based production and distinctive improvement of therapeutic items.
Media Speak to:
[email protected] health
This news release might include “forward-seeking statements” inside the which means of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements relate to future events or future overall performance. Statements which are not purely historical are forward-seeking statements and consist of any statements concerning beliefs, plans, outlook, expectations or intentions concerning the future such as words or phrases such as “anticipate”, “come to be”, “objective”, “might”, “will”, “may”, “really should”, “could”, “can”, “intend”, “anticipate”, “think”, “estimate”, “predict”, “possible”, “program”, “is made to”, “project”, “continue”, or comparable expressions recommend future outcomes or the damaging thereof or comparable variations. Such forward-seeking statements consist of, but are not restricted to, that the Corporation will encounter development and will be in a position to expand globally.. We are also topic to different further dangers as described in our SEC filings at www.SEC.gov.
Forward-seeking statements are primarily based on management’s existing expectations and might materially differ from actual benefits. Additional, such forward-seeking statements and are topic to dangers and uncertainties that could negatively impact our enterprise, operating benefits, economic situation and stock value.
We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-seeking statements contained herein to reflect any adjust in our expectations or any adjust in events, circumstances or situations on which any such statement is primarily based, except as needed by law.